FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306860747> ?p ?o ?g. }

• W4306860747 endingPage "69" @default.
• W4306860747 startingPage "63" @default.
• W4306860747 abstract "Objectives To assess treatment patterns and initial and maintenance dosing of biologics over 3 years in pediatric patients with ulcerative colitis (UC) or Crohn’s disease (CD), utilizing data from the ImproveCareNow registry.Methods Pediatric patients diagnosed with UC or CD and aged 2–17 years were included in the study. Descriptive statistics were employed to summarize baseline demographics. The proportion of patients on medication for UC or CD were analyzed at the baseline visit, 1-year, and 3-year time points (Cohort 1). Biologic maintenance dosage was calculated only for patients who had data for dose and weight at all-time points (Cohort 2).Results In Cohort 1 (UC = 1784; CD = 4720), baseline treatment in UC included corticosteroid, 5-ASA, and 6-MP/AZA; at 1-year and 3-year time points, treatment with 5-ASA and corticosteroid decreased, whereas 6-MP/AZA and anti-TNFs increased. In CD, baseline treatment included corticosteroid, anti-TNF, 6-MP/AZA, and methotrexate; use of corticosteroids decreased, whereas the use of methotrexate and anti-TNFs increased over 3 years. In Cohort 2 (UC = 350; CD = 1537), at first maintenance dose, UC patients on infliximab received a mean dose of 10.5 mg/kg/8 wk, adalimumab (weight < 40 kg and ≥40 kg) 1.3 mg/kg/2 wk and 0.8 mg/kg/2 wk, and vedolizumab 6.9 mg/kg/8 wks. At the first maintenance dose, CD patients on infliximab received a mean dose of 8.1 mg/kg/8 wk, adalimumab (weight < 40 kg) 1.1 mg/kg/2 wk, adalimumab (weight ≥ 40 kg) 0.8 mg/kg/2 wk, and vedolizumab 10.5 mg/kg/8 wks.Conclusion The use of corticosteroids was common at the initial visit in patients. Anti-TNFs remain the most used class of biologics, however, reported doses in our study were substantially higher than the standard dosing guidelines." @default.
• W4306860747 created "2022-10-20" @default.
• W4306860747 creator A5003443804 @default.
• W4306860747 creator A5006524407 @default.
• W4306860747 creator A5012036200 @default.
• W4306860747 creator A5029370567 @default.
• W4306860747 creator A5040825774 @default.
• W4306860747 creator A5054537181 @default.
• W4306860747 creator A5084322545 @default.
• W4306860747 creator A5087620957 @default.
• W4306860747 creator A5091537631 @default.
• W4306860747 date "2022-11-07" @default.
• W4306860747 modified "2023-09-27" @default.
• W4306860747 title "Treatment and biologic maintenance-dosing patterns among pediatric patients with ulcerative colitis or Crohn’s disease" @default.
• W4306860747 cites W1825587443 @default.
• W4306860747 cites W1915598702 @default.
• W4306860747 cites W1964704603 @default.
• W4306860747 cites W1975391202 @default.
• W4306860747 cites W1981017999 @default.
• W4306860747 cites W1997919668 @default.
• W4306860747 cites W2003835888 @default.
• W4306860747 cites W2011135579 @default.
• W4306860747 cites W2022876395 @default.
• W4306860747 cites W2036144913 @default.
• W4306860747 cites W2043780895 @default.
• W4306860747 cites W2057141381 @default.
• W4306860747 cites W2062369130 @default.
• W4306860747 cites W2066953275 @default.
• W4306860747 cites W2070402792 @default.
• W4306860747 cites W2092196906 @default.
• W4306860747 cites W2117572037 @default.
• W4306860747 cites W2144518079 @default.
• W4306860747 cites W2149170290 @default.
• W4306860747 cites W2155938603 @default.
• W4306860747 cites W2297516805 @default.
• W4306860747 cites W2304888147 @default.
• W4306860747 cites W2549411388 @default.
• W4306860747 cites W2587731986 @default.
• W4306860747 cites W2802821602 @default.
• W4306860747 cites W2919081348 @default.
• W4306860747 cites W2960010825 @default.
• W4306860747 cites W2978765478 @default.
• W4306860747 cites W2999392094 @default.
• W4306860747 cites W2999873106 @default.
• W4306860747 cites W3000044922 @default.
• W4306860747 cites W3092023159 @default.
• W4306860747 cites W4200156725 @default.
• W4306860747 cites W4206405543 @default.
• W4306860747 cites W4210662453 @default.
• W4306860747 cites W4210728052 @default.
• W4306860747 doi "https://doi.org/10.1080/03007995.2022.2135836" @default.
• W4306860747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36263735" @default.
• W4306860747 hasPublicationYear "2022" @default.
• W4306860747 type Work @default.
• W4306860747 citedByCount "0" @default.
• W4306860747 crossrefType "journal-article" @default.
• W4306860747 hasAuthorship W4306860747A5003443804 @default.
• W4306860747 hasAuthorship W4306860747A5006524407 @default.
• W4306860747 hasAuthorship W4306860747A5012036200 @default.
• W4306860747 hasAuthorship W4306860747A5029370567 @default.
• W4306860747 hasAuthorship W4306860747A5040825774 @default.
• W4306860747 hasAuthorship W4306860747A5054537181 @default.
• W4306860747 hasAuthorship W4306860747A5084322545 @default.
• W4306860747 hasAuthorship W4306860747A5087620957 @default.
• W4306860747 hasAuthorship W4306860747A5091537631 @default.
• W4306860747 hasConcept C126322002 @default.
• W4306860747 hasConcept C141071460 @default.
• W4306860747 hasConcept C2776694085 @default.
• W4306860747 hasConcept C2776804153 @default.
• W4306860747 hasConcept C2777138892 @default.
• W4306860747 hasConcept C2777288759 @default.
• W4306860747 hasConcept C2778260677 @default.
• W4306860747 hasConcept C2778283404 @default.
• W4306860747 hasConcept C2779134260 @default.
• W4306860747 hasConcept C2780132546 @default.
• W4306860747 hasConcept C2780479503 @default.
• W4306860747 hasConcept C2781059491 @default.
• W4306860747 hasConcept C27924281 @default.
• W4306860747 hasConcept C70917649 @default.
• W4306860747 hasConcept C71924100 @default.
• W4306860747 hasConcept C72563966 @default.
• W4306860747 hasConcept C90924648 @default.
• W4306860747 hasConceptScore W4306860747C126322002 @default.
• W4306860747 hasConceptScore W4306860747C141071460 @default.
• W4306860747 hasConceptScore W4306860747C2776694085 @default.
• W4306860747 hasConceptScore W4306860747C2776804153 @default.
• W4306860747 hasConceptScore W4306860747C2777138892 @default.
• W4306860747 hasConceptScore W4306860747C2777288759 @default.
• W4306860747 hasConceptScore W4306860747C2778260677 @default.
• W4306860747 hasConceptScore W4306860747C2778283404 @default.
• W4306860747 hasConceptScore W4306860747C2779134260 @default.
• W4306860747 hasConceptScore W4306860747C2780132546 @default.
• W4306860747 hasConceptScore W4306860747C2780479503 @default.
• W4306860747 hasConceptScore W4306860747C2781059491 @default.
• W4306860747 hasConceptScore W4306860747C27924281 @default.
• W4306860747 hasConceptScore W4306860747C70917649 @default.
• W4306860747 hasConceptScore W4306860747C71924100 @default.
• W4306860747 hasConceptScore W4306860747C72563966 @default.

• next